Acute liver failure

  • William M. Lee
    Requests for reprints should be addressed to William M. Lee, M.D., the Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235-8887.
    Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.


      Acute liver failure is a multiorgan syndrome with dramatic clinical features and, often, a fatal outcome. It is characterized by the onset of coma and coagulopathy within 6 months, and usually in <6 weeks, from onset of illness. Viral hepatitis, drug-related liver injury, and the alcohol-acetaminophen syndrome are the most common etiologies. Altered mental status accompanied by jaundice is a hallmark of acute liver failure. A unique feature is the evolution of increased intracranial pressure due to cerebral edema. The resulting cerebral ischemia and brainstem herniation account for approximately 50% of deaths in patients with acute liver failure. Mannitol therapy may successfully treat most patients with high intracerebral pressure. Most patients demonstrate features of the multiple organ failure syndrome, including a shock-like state, renal failure, and occasionally respiratory distress syndrome. Close monitoring of volume status is necessary, since administration of large quantities of fluid may be required. Infection is also common; most pathogens are gram-positive, and fungal infections are also seen. Because an optimum therapy for acute liver failure does not yet exist, liver transplantation should be considered early, before advanced levels of coma develop. Alternative, experimental treatment modalities include heterotopic liver grafting, administration of hepatocyte growth factor, use of an extracorporeal liver-assist device, and liver cell transplantation, but none of these has attained widespread use.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lee WM
        Medical progress: acute liver failure.
        N Engl J Med. 1993; 329: 1862-1872
        • Bernuau J
        • Rueff B
        • Benhamou JP
        Fulminant and subfulminant liver failure: definitions and causes.
        Semin Liver Dis. 1986; 6: 97-106
        • Gimson AES
        • O'Grady J
        • Ede RJ
        • Portmann B
        • Williams R
        Late onset hepatic failure: clinical, serological and histological features.
        Hepatology. 1986; 6: 288-294
        • O'Grady JG
        • Schalm SW
        • Williams R
        Acute liver failure: redefining the syndromes.
        Lancet. 1993; 342: 273-275
        • Schalm SW
        • de Knegt RJ
        Acute liver failure: definitions and pathological variants.
        in: Williams R Hughes RD Acute Liver Failure: Improved Understanding and Better Therapy. Miter Press, London1991: 11-13
        • Jones EA
        • Schafer DR
        Fulminant hepatic failure.
        in: Zakim D Boyer TD Hepatology. 2nd ed. Harcourt Brace Jovanovich, Philadelphia1990: 462
        • Seeff LB
        • Cuccherini BA
        • Zimmerman HJ
        • Adler E
        • Benjamin SB
        Acetaminophen hepatotoxicity in alcoholics.
        Ann Intern Med. 1986; 104: 399-404
        • Benhamou JP
        Fulminant and subfulminant hepatic failure: definition and causes.
        in: Williams R Hughes RD Acute Liver Failure: Improved Understanding and Better Therapy. Miter Press, London1991: 6-10
        • Akriviadis EA
        • Redeker AG
        Fulminant hepatitis A in intravenous drug users with chronic liver disease.
        Ann Intern Med. 1989; 110: 838-839
        • Bernuau J
        • Goudeau A
        • Poynard T
        • et al.
        Multivariate analysis of prognostic factors in fulminant hepatitis B.
        Hepatology. 1986; 6: 648-651
        • Carman WF
        • Jacyna MR
        • Hadziyannis S
        • et al.
        Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.
        Lancet. 1989; ii: 588-591
        • Feray C
        • Gigou M
        • Samuel D
        • et al.
        Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.
        Gastroenterology. 1993; 104: 549-555
        • Smedile A
        • Verme G
        • Cargnel A
        • et al.
        Influence of delta infection on severity of hepatitis B.
        Lancet. 1982; ii: 945-947
        • Herrera JL
        Hepatitis E as a cause of acute non-A, non-B hepatitis.
        Arch Intern Med. 1993; 153: 773-775
        • Christie AB
        • Allam AA
        • Aref MK
        • El Muntasser IH
        • El-Nageh M
        Pregnancy hepatitis in Libya.
        Lancet. 1976; ii: 827-829
        • Craske J
        Hepatitis C and non-A non-B hepatitis revisited: hepatitis E, F and G.
        J Infection. 1992; 25: 243-250
        • Zimmerman HJ
        • Maddrey WC
        Toxic and drug-induced hepatitis.
        in: Schiff L Schiff ER Diseases of the Liver. Lippincott, Philadelphia1993: 707-783
        • Larrey D
        • Vial T
        • Micaleff A
        • et al.
        Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.
        Gut. 1992; 33: 368-371
        • Moulding TS
        • Redeker AG
        • Kanel GC
        Acetaminophen, isoniazid and hepatic toxicity.
        Ann Intern Med. 1991; 114: 431
        • Licht H
        • Seeff LB
        • Zimmerman HJ
        Apparent potentiation of acetaminophen hepatotoxicity by alcohol.
        Ann Intern Med. 1990; 92: 511
        • Ware AJ
        • D'Agostino AN
        • Combes B
        Cerebral edema: a major complication of massive hepatic necrosis.
        Gastroenterology. 1971; 61: 877-884
        • Blei AT
        Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem.
        Hepatology. 1991; 13: 376-379
        • Canalese J
        • Gimson AES
        • Davis C
        • Mellon PJ
        • Davis M
        • Williams R
        Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure.
        Gut. 1982; 23: 625-629
        • Lidofsky SD
        • Bass NM
        • Prager MC
        • et al.
        Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure.
        Hepatology. 1992; 16: 1-7
        • Pereira LMMB
        • Langley PG
        • Hayllar KM
        • Tredger JM
        • Williams R
        Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.
        Gut. 1992; 33: 98-102
        • Wendon J
        • Alexander GJM
        • Williams R
        Cardiovascular monitoring and local blood flow.
        in: Williams R Hughes RD Acute Liver Failure: Improved Understanding and Better Therapy. Miter Press, London1991: 39-41
        • Bihari D
        • Gimson AES
        • Waterson M
        • Williams R
        Tissue hypoxia during fulminant hepatic failure.
        Crit Care Med. 1985; 13: 1034-1039
        • MacNaughton PD
        • Evans TW
        Management of adult respiratory distress syndrome.
        Lancet. 1992; 339: 469-472
        • Harrison PM
        • Wendon JA
        • Gimson AES
        • Alexander GJM
        • Williams R.
        Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure.
        N Engl J Med. 1991; 324: 1852-1857
        • Rolando N
        • Harvey F
        • Brahm J
        • et al.
        Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients.
        Hepatology. 1990; 11: 49-53
        • Rolando N
        • Gimson A
        • Wade J
        • Philpott-Howard J
        • Casewall M
        • Williams R
        Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure.
        Hepatology. 1993; 17: 196-201
        • MacDougall BRD
        • Williams R
        H2-receptor antagonist in the prevention of acute upper gastrointestinal hemorrhage in fulminant hepatic failure.
        in: A controlled trial. 2nd ed. Gastroenterology. 74. 1978: 464-465
        • Benhamou J-P
        • Rueff B
        • Sicot C
        Severe hepatic failure: a critical study of current therapy.
        in: Orlandi F Jezequel AM Liver and Drugs. Academic Press, New York1972: 213-218
        • Berger RL
        • Liversage RM
        • Chalmers TC
        • Graham JH
        • McGoldrick DM
        • Stohlman F
        Exchange transfusion in the treatment of fulminating hepatitis.
        N Engl J Med. 1966; 274: 497-500
        • Abecassis M
        • Falk JA
        • Makowka L
        • Dindzans VJ
        • Falk RE
        • Levy GA
        16,16-dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.
        J Clin Invest. 1987; 80: 881-889
        • Guarner F
        • Boughton-Smith NK
        • Blackwell GJ
        • Moncada S
        Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouse.
        Hepatology. 1988; 8: 248-253
        • Sinclair SB
        • Greig PD
        • Blendis LM
        • et al.
        Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E.
        J Clin Invest. 1989; 84: 1063-1069
        • Sheiner P
        • Sinclair S
        • Greig P
        • Logan A
        • Blendis LM
        • Levy G
        A randomized control trial of prostaglandin E2 (PGE2) in the treatment of fulminant hepatic failure (FHF).
        Hepatology. 1992; 16: 88A
        • O'Grady JG
        • Alexander GJM
        • Hayllar KM
        • Williams R
        Early indicators of prognosis in fulminant hepatic failure.
        Gastroenterology. 1989; 97: 439-445
        • Campbell DA
        • Ham JM
        • McCurry KR
        • Lucey MR
        • Turcotte JG
        • Merion RM
        Liver transplant for fulminant hepatic failure.
        Am Surg. 1991; 57: 546-549
        • Devictor D
        • Desplanques L
        • Debray D
        • et al.
        Emergency liver transplantation for fulminant liver failure in infants and children.
        Hepatology. 1992; 16: 1156-1162
        • Metselaar HJ
        • Hesslink EJ
        • de Rave S
        • et al.
        Recovery of failing liver after auxiliary heterotopic transplantation.
        Lancet. 1990; 335: 1156-1157
        • Gohda E
        • Tsubouchi H
        • Nakayama H
        • et al.
        Human hepatocyte growth factor in blood of patients with fulminant hepatic failure.
        in: Basic aspects. 2nd ed. Dig Dis Sci. 36. 1991: 785-790
        • Tashiro K
        • Hagiya M
        • Nishizawa T
        • et al.
        Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues.
        in: 2nd ed. Proc Natl Acad Sci USA. 87. 1990: 3200-3204
        • Sussman NL
        • Chong MG
        • Koussayer T
        • et al.
        Reversal of fulminant hepatic failure using an extracorporeal liver assist device.
        Hepatology. 1992; 16: 60-65
        • Demetriou AA
        • Chowdhury NR
        • Michalski S
        • et al.
        New method of hepatocyte transplantation and extracorporeal liver support.
        Ann Surg. 1986; 204: 259-271
        • Hughes RD
        • Wendon J
        • Gimson AES
        Acute liver failure.
        Gut. 1991; (Suppl): S86-S91
        • O'Grady JG
        • Tan KC
        • Williams R
        Selection criteria and results of orthotopic liver transplantation in the UK.
        in: Williams R Hughes RD Acute Liver Failure: Improved Understanding and Better Therapy. Miter Press, London1991: 77-80
        • O'Grady JG
        • Gimson AES
        • O'Brien CJ
        • Pucknell A
        • Hughes RD
        • Williams R
        Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.
        Gastroenterology. 1988; 94: 1186-1192